Skip to main content
. 2016 May 27;27(2):69–78. doi: 10.1089/humc.2016.031

Figure 3.

Figure 3.

Immunocompetent BALB/c mice were injected subcutaneously with 1 × 105 neuro-2A cells. When tumors attained 200 mm3 in volume, they were injected with 50 liters of saline or 5 × 107 PFU of HSV R3659 or M002. Tumor volumes were measured every 3 days, and the average percentage increase in volume was calculated relative to the treatment date.